Consilient Health
Consilient Health, a prominent player in the pharmaceutical industry, is headquartered in Great Britain and operates across various regions, focusing on the development and commercialisation of innovative healthcare solutions. Founded in 2010, the company has achieved significant milestones, establishing itself as a trusted partner in the healthcare sector. Specialising in prescription medicines and healthcare products, Consilient Health is known for its unique approach to addressing unmet medical needs. Their portfolio includes a range of therapeutic areas, with a commitment to quality and patient-centric solutions that set them apart in a competitive market. With a strong market position, Consilient Health has garnered recognition for its strategic partnerships and successful product launches, reinforcing its reputation as a leader in the pharmaceutical landscape.
DitchCarbon Score
How does Consilient Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Consilient Health's score of 29 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Consilient Health's reported carbon emissions
In 2023, Consilient Health reported total carbon emissions of approximately 6,749,300 kg CO2e, with no emissions from Scope 1 and 6,500 kg CO2e from Scope 2. The majority of their emissions stem from Scope 3, which accounted for about 6,742,800 kg CO2e. Notably, emissions from capital goods were significant, contributing approximately 6,083,600 kg CO2e. Consilient Health has set ambitious climate commitments, aiming to reduce Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030 from a 2021 baseline. Additionally, they are committed to measuring and reducing their Scope 3 emissions. By 2050, the company targets an overall reduction of 90% across all scopes (1, 2, and 3) from the same baseline year. These targets have been validated through the Science Based Targets initiative (SBTi), aligning with the goal of limiting global warming to 1.5°C. As a small to medium enterprise based in the UK, Consilient Health is actively working towards a sustainable future, demonstrating a strong commitment to environmental responsibility within the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | 2,100 | 0,000 |
| Scope 3 | 6,749,300 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Consilient Health is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
